Ricardo Parrondo

45PUBLICATIONS
199CO-AUTHORS
AutoimmunityHaematological tumoursRadiation therapyCellular immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jun 01, 2026
Wandering Lymphoma: A Case of Wandering Spleen Secondary to Splenic Marginal Zone Lymphoma.

|May 07, 2026
A phase II study of daratumumab and ibrutinib for relapsed/refractory chronic lymphocytic leukemia.

|Apr 22, 2026
A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

|Apr 10, 2026
Diagnosis and management of immune effector cell-associated enterocolitis after ciltacabtagene autoleucel.

Kenneth Jc Lim, Hee Eun Lee, Zongming Eric Chen

|Mar 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapy.

Joselle Cook, Supriya Gupta, Nadine Abdallah

|Feb 25, 2026
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front-Line Daratumumab Lenalidomide and Dexamethasone.

Ricardo D Parrondo, Ricardo C B de Menezes, Hanna Sledge

Pageof 8

Frequent Collaborators

19 joint publications

Sikander Ailawadhi

13 joint publications

Saurabh Chhabra

13 joint publications

Shaji Kumar

11 joint publications

Vivek Roy